CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / NAMEN AKT
Number of holders
441
Total Shares
59.5M
Shares change
+1.86M
Total reported value, excl. options
$3.21B
Value change
+$82.2M
Put/Call ratio
1.07
Number of buys
195
Number of sells
-198
Price
$54.01
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.